1. Home
  2. PNNT vs PRTC Comparison

PNNT vs PRTC Comparison

Compare PNNT & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNNT
  • PRTC
  • Stock Information
  • Founded
  • PNNT 2007
  • PRTC 2015
  • Country
  • PNNT United States
  • PRTC United States
  • Employees
  • PNNT N/A
  • PRTC N/A
  • Industry
  • PNNT Finance: Consumer Services
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNNT Finance
  • PRTC Health Care
  • Exchange
  • PNNT Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • PNNT 462.3M
  • PRTC 414.6M
  • IPO Year
  • PNNT 2007
  • PRTC N/A
  • Fundamental
  • Price
  • PNNT $6.48
  • PRTC $17.25
  • Analyst Decision
  • PNNT Hold
  • PRTC Buy
  • Analyst Count
  • PNNT 3
  • PRTC 1
  • Target Price
  • PNNT $6.00
  • PRTC $45.00
  • AVG Volume (30 Days)
  • PNNT 535.4K
  • PRTC 4.0K
  • Earning Date
  • PNNT 05-12-2025
  • PRTC 04-30-2025
  • Dividend Yield
  • PNNT 14.81%
  • PRTC N/A
  • EPS Growth
  • PNNT 11.30
  • PRTC N/A
  • EPS
  • PNNT 0.83
  • PRTC 0.21
  • Revenue
  • PNNT $143,689,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • PNNT N/A
  • PRTC $35.98
  • Revenue Next Year
  • PNNT N/A
  • PRTC $115.38
  • P/E Ratio
  • PNNT $7.79
  • PRTC $7.39
  • Revenue Growth
  • PNNT N/A
  • PRTC 44.98
  • 52 Week Low
  • PNNT $5.72
  • PRTC $13.30
  • 52 Week High
  • PNNT $8.04
  • PRTC $32.98
  • Technical
  • Relative Strength Index (RSI)
  • PNNT 48.54
  • PRTC 49.49
  • Support Level
  • PNNT $6.34
  • PRTC $17.41
  • Resistance Level
  • PNNT $6.60
  • PRTC $18.05
  • Average True Range (ATR)
  • PNNT 0.15
  • PRTC 0.39
  • MACD
  • PNNT 0.03
  • PRTC 0.06
  • Stochastic Oscillator
  • PNNT 77.68
  • PRTC 54.70

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

Share on Social Networks: